Inflammatory Bowel Disease ("IBD")
IBD is an umbrella term used to describe disorders that involve chronic inflammation of the digestive tract. This condition causes long-lasting inflammation and sores (ulcers) in the innermost lining of the large intestine (colon) and rectum.
According to Transparency Market Research, the global IBD treatment market is valued at US$10.52 Billion in 2016. Rising at a steady 2.6% CAGR between 2017 and 2025, the market is likely to be valued at US$14.8 Billion by the end of 2025. In 2016, North America led the global IBD market, which is attributable to the rising incidence of the disease witnessed among men and women alike in the region. The incidence of ulcerative colitis and Crohn's disease is high in US and Canada, which fuels the demand for IBD treatment in North America.
(in US$ Billions)
*According to Transparency Market Research.